Adriano Martinelli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Adriano Martinelli has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Maria Anna Rapsomaniki
Biomedical Data Science Center, Lausanne University Hospital, Lausanne, Switzerland; Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland
3 shared publications - Aditya Kashyap
IBM Research Europe -Säumerstrasse 4, Rüschlikon CH-8803, Zurich, Switzerland
1 shared publication - Andreas Gloger
Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland
1 shared publication - Anna Fomitcheva Khartchenko
Department of Bioengineering, University of California Berkeley, Berkeley, California 94720, United States
1 shared publication - Antonio Foncubierta-Rodriguez
IBM Research Europe, Zurich, Switzerland
1 shared publication - Bastien Dietschi
Department of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich, Switzerland
1 shared publication
Latest Publications
- Open Access
- 6 March 2026
- Published by The Open Journal in Journal of Open Source Software
- Vol. 11 (119) , 8780
SpatialProteomicsNet: A unified interface for spatial proteomics data access for computer vision and machine learning
- 6 March 2026
- Published by The Open Journal in Journal of Open Source Software
- Vol. 11 (119) , 8780
Open AccessSpatialProteomicsNet: A unified interface for spatial proteomics data access for computer vision and machine learning
- 14 June 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 384 (6701) , 1259-1265
Highly pure DNA-encoded chemical libraries by dual-linker solid-phase synthesis
The first drugs discovered using DNA-encoded chemical library (DEL) screens have entered late-stage clinical development. However, DEL technology as a whole still suffers from poor chemical purity resulting in suboptimal performance. In this work, we report a technique to overcome this issue through self-purifying release of the DEL after magnetic bead–based synthesis. Both the first and last building blocks of each assembled library member were linked to the beads by tethers that could be cleaved by mutually orthogonal chemistry. Sequential cleavage of the first and last tether, with washing in between, ensured that the final library comprises only the fully complete compounds. The outstanding purity attained by this approach enables a direct correlation of chemical display and encoding, allows for an increased chemical reaction scope, and facilitates the use of more diversity elements while achieving greatly improved signal-to-noise ratios in selections.
- 14 June 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 384 (6701) , 1259-1265
Highly pure DNA-encoded chemical libraries by dual-linker solid-phase synthesis
The first drugs discovered using DNA-encoded chemical library (DEL) screens have entered late-stage clinical development. However, DEL technology as a whole still suffers from poor chemical purity resulting in suboptimal performance. In this work, we report a technique to overcome this issue through self-purifying release of the DEL after magnetic bead–based synthesis. Both the first and last building blocks of each assembled library member were linked to the beads by tethers that could be cleaved by mutually orthogonal chemistry. Sequential cleavage of the first and last tether, with washing in between, ensured that the final library comprises only the fully complete compounds. The outstanding purity attained by this approach enables a direct correlation of chemical display and encoding, allows for an increased chemical reaction scope, and facilitates the use of more diversity elements while achieving greatly improved signal-to-noise ratios in selections.
- Open Access
Multiplexed tumor profiling with generative AI accelerates histopathology workflows and improves clinical predictions
Understanding the spatial heterogeneity of tumors and its links to disease is a cornerstone of cancer biology. Emerging spatial technologies offer unprecedented capabilities towards this goal, but several limitations hinder their clinical adoption. To date, histopathology workflows still heavily depend on hematoxylin & eosin (H&E) and serial immunohistochemistry (IHC) staining, a cumbersome and tissue-exhaustive process that yields unaligned tissue images. We propose the VirtualMultiplexer, a generative AI toolkit that translates real H&E images to matching IHC images for several markers based on contrastive learning. The VirtualMultiplexer learns from unpaired H&E and IHC images and introduces a novel multi-scale loss to ensure consistent and biologically reliable stainings. The virtually multiplexed images enabled training a Graph Transformer that simultaneously learns from the joint spatial distribution of several markers to predict clinically relevant endpoints. Our results indicate that the VirtualMultiplexer achieves rapid, robust and precise generation of virtually multiplexed imaging datasets of high staining quality that are indistinguishable from the real ones. We successfully employed transfer learning to generate realistic virtual stainings across tissue scales, patient cohorts, and cancer types with no need for model fine-tuning. Crucially, the generated images are not only realistic but also clinically relevant, as they greatly improved the prediction of different clinical endpoints across patient cohorts and cancer types, speeding up histopathology workflows and accelerating spatial biology.
Open AccessMultiplexed tumor profiling with generative AI accelerates histopathology workflows and improves clinical predictions
Understanding the spatial heterogeneity of tumors and its links to disease is a cornerstone of cancer biology. Emerging spatial technologies offer unprecedented capabilities towards this goal, but several limitations hinder their clinical adoption. To date, histopathology workflows still heavily depend on hematoxylin & eosin (H&E) and serial immunohistochemistry (IHC) staining, a cumbersome and tissue-exhaustive process that yields unaligned tissue images. We propose the VirtualMultiplexer, a generative AI toolkit that translates real H&E images to matching IHC images for several markers based on contrastive learning. The VirtualMultiplexer learns from unpaired H&E and IHC images and introduces a novel multi-scale loss to ensure consistent and biologically reliable stainings. The virtually multiplexed images enabled training a Graph Transformer that simultaneously learns from the joint spatial distribution of several markers to predict clinically relevant endpoints. Our results indicate that the VirtualMultiplexer achieves rapid, robust and precise generation of virtually multiplexed imaging datasets of high staining quality that are indistinguishable from the real ones. We successfully employed transfer learning to generate realistic virtual stainings across tissue scales, patient cohorts, and cancer types with no need for model fine-tuning. Crucially, the generated images are not only realistic but also clinically relevant, as they greatly improved the prediction of different clinical endpoints across patient cohorts and cancer types, speeding up histopathology workflows and accelerating spatial biology.
- Open Access
- 1 June 2022
- Published by Elsevier in Trends in Biotechnology
- Vol. 40 (6) , 647-676
Quantification of tumor heterogeneity: from data acquisition to metric generation
- 1 June 2022
- Published by Elsevier in Trends in Biotechnology
- Vol. 40 (6) , 647-676
Open AccessQuantification of tumor heterogeneity: from data acquisition to metric generation